Viatris Inc (VTRS)

10.93
+0.01(+0.09%)
After Hours
10.85
-0.08(-0.73%)
- Real-time Data
  • Volume:
    6,245,937
  • Day's Range:
    10.77 - 11.00
  • 52 wk Range:
    8.42 - 15.60
High dividend Yield

Dividend yield shows how much a company pays its shareholders in dividends annually per dollar invested. It reflects how much an investor will earn aside from any capital gains in the stock.

VTRS Overview

Prev. Close
10.92
Day's Range
10.77-11
Revenue
17.15B
Open
10.9
52 wk Range
8.42-15.6
EPS
0.663
Volume
6,245,937
Market Cap
13.25B
Dividend (Yield)
0.48
(4.39%)
Average Volume (3m)
9,935,969
P/E Ratio
16.64
Beta
1.19
1-Year Change
-12.14%
Shares Outstanding
1,212,668,761
Next Earnings Date
Feb 27, 2023
What is your sentiment on Viatris?
or
Market is currently closed. Voting is open during market hours.

Viatris Inc News

Viatris Inc Analysis

Viatris Inc Company Profile

Viatris Inc Company Profile

Employees
37000

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides its medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as offers biosimilars franchises, including Fulphila, Ogivri, Hulio, and SEMGLEE. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; Momenta Pharmaceuticals, Inc.; Theravance Biopharma, Inc.; Biocon Ltd.; and Fujifilm Kyowa Kirin Biologics Co. Ltd. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.

Read More

Analyst Price Target

Average13.27 (+21.43% Upside)
High18
Low10
Price10.93
No. of Analysts11
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyBuyNeutralBuySell
Technical IndicatorsStrong BuyStrong BuyStrong SellSellStrong Sell
SummaryStrong BuyStrong BuySellNeutralStrong Sell